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Purpose of the study
to assess the immunological response at 5 years in HIV-
1 infected patients under ART and with persistently
undetectable plasma viral load.
Methods
of 1450 patients currently on ART, 504 HIV-1 infected
patients with persistently undetectable viral load for 5 or
more years (mean = 8±2 years) were selected. Results of
plasma viral load (performed by PCR RNA-HIV, Ampli-
cor 1.5®) and CD4 count of all patients obtained every 3
or 6 months were abstracted. The distribution of 5-year
CD4 count was described using medians and compared
between classes of clinical and demographic variables
using Wilcoxon’so rK r u s k a l - W a l l i s ’ test. Variation in
CD4 count over 5 years was described using means and
compared between classes using Student’stt e s to r
ANOVA. In order to quantify the associations between
independent variables and CD4 count variation, linear
regression coefficients and respective 95% confidence
intervals (95% CI) were calculated, and adjusted for sex,
naïve status, transmission mode, baseline viral load and
age at viral load suppression.
Summary of results
In crude analysis, 5-year CD4 count (per mm
3)w a ss i g -
nificantly higher in women (medians: 656 vs. 573,
p=0.006), in younger patients (<30 years-old: 656 vs. 526
in those over 49), in non-AIDS patients (637 vs. 513.5
in AIDS patients, p<0.001) and in those with the highest
baseline CD4 count (>350: 826 vs. 459 in those under
100; p<0.001). Mean CD4 variation was greater in
women (467.5 vs. 401.3, p=0.022), in naïve patients
(437.9 vs. 361.8, p=0.006), in those with the highest
baseline viral load (>750000 copies: 490.3 vs. 271.0 in
those under 10000 copies) and correspondingly in
patients with the lowest baseline CD4 count (<100:
469.7 vs. 359.5 in those over 350). Patients on NNRTI
had larger improvement than those on PI (436.2 vs.
403.0) but no significant differences in CD4 count were
found after 5 years. In multivariate analysis, mean CD4
count improvement remained significantly higher in
women and lower in older patients. Improvement was
also directly associated with baseline viral load.
Conclusions
Even though patients with the lowest CD4 count at base-
line had greater immunological improvement over
5 years, average CD4 count remained lower than in those
whose baseline count was higher. Importantly, the gap in
immunological response (regarding final CD4 count and
mean improvement) widened over the follow-up period
between women and men and between younger and
older patients.
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